Uncategorized

CAPA Survival Playbooks — Kandih Bioscience A CAPA that does not result in a Design History File (DHF) update is not effective in FDA’s eyes.From an […]

CAPA Survival Playbooks — Kandih Bioscience From an inspection perspective, a CAPA that stops in QA without informing design inputs, risk management, or validation is incomplete. […]

CAPA Survival Playbooks — Kandih Bioscience Complaint-to-CAPA mapping is a risk-interpretation system, not an administrative checklist.FDA evaluates whether complaint signals are consistently interpreted, escalated, or deferred […]

Yes—FDA expects complaint trending before CAPA initiation.From an inspection perspective, complaint trending is a diagnostic function, not an effectiveness check. If trending only occurs after CAPA […]